Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden

The Background links HSV-1 to increased AD risk, and the Results associate untreated herpes infection with increased overall dementia risk and antiviral treatment with decreased overall risk. However, the Methods and Discussion show that the study did not distinguish HSV-1 from other HSV infections or analyze AD, vascular dementia, and other dementia subtypes separately. The Conclusion also cautions that the observed antiviral association does not establish a causal reduction in risk (page numbers unavailable). (LLM, conf=0.90)

The Discussion (page not provided) reports increased dementia risk among people diagnosed with HSV infection (HR 1.38), consistent with the claim's central point. However, the study could not classify HSV infections by subtype, so it does not establish the finding specifically for HSV-1 and/or HSV-2; its diagnoses also represent a subgroup with symptomatic infection rather than all carriers. (LLM, conf=0.86)

The Discussion reports an association between VZV diagnosis and increased dementia risk, and an association between antiviral treatment and reduced dementia risk. But it says the study did not analyze AD and vascular dementia separately because dementia subtypes were often misclassified; it does not establish a VZV link to each subtype. The reported antiviral effect is observational, not proof that treatment caused the reduction. (LLM, conf=0.90)

The Background links HSV-1 to increased Alzheimer’s disease risk and VZV to increased dementia risk. The Discussion reports higher dementia risk for diagnosed HSV and VZV infections, but says the study could not classify HSV infections by subtype. It therefore does not establish the stated risk for HSV-2 specifically. (LLM, conf=0.88)